NM_001148.6:c.85-51835T>A

Variant names:

• chr4-113122581-T-A
• rs13131206
• NM_001148.6:c.85-51835T>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_001148.6(ANK2):​c.85-51835T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.688 in 151,844 control chromosomes in the GnomAD database, including 36,250 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.69 (36250 hom., cov: 30)
• Consequence: ANK2 NM_001148.6 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.107
• Publications: 1 publications found

Genes affected

ANK2 (HGNC:493): (ankyrin 2) This gene encodes a member of the ankyrin family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton. Ankyrins play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. The protein encoded by this gene is required for targeting and stability of Na/Ca exchanger 1 in cardiomyocytes. Mutations in this gene cause long QT syndrome 4 and cardiac arrhythmia syndrome. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Dec 2011]

ANK2 Gene-Disease associations (from GenCC):

• complex neurodevelopmental disorder

  Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
• Brugada syndrome

  Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen
• catecholaminergic polymorphic ventricular tachycardia

  Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
• heart conduction disease

  Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
• neurodevelopmental disorder

  Inheritance: AD Classification: LIMITED Submitted by: G2P
• cardiac arrhythmia, ankyrin-B-related

  Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
• long QT syndrome

  Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.86).
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.712 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001148.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	ANK2	NM_001148.6	MANE Select	c.85-51835T>A		intron	N/A	NP_001139.3
	ANK2	NM_001386142.1		c.22-51835T>A		intron	N/A	NP_001373071.1
	ANK2	NM_001386143.1		c.22-51835T>A		intron	N/A	NP_001373072.1

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	ANK2	ENST00000357077.9	TSL:1 MANE Select	c.85-51835T>A		intron	N/A	ENSP00000349588.4
	ANK2	ENST00000394537.7	TSL:1	c.85-51835T>A		intron	N/A	ENSP00000378044.3
	ANK2	ENST00000506722.5	TSL:1	c.22-51835T>A		intron	N/A	ENSP00000421067.1

Frequencies

GnomAD3 genomes AF: 0.688 AC: 104407 AN: 151726 Hom.: 36215 Cov.: 30

Gnomad AFR AF: 0.718

Gnomad AMI AF: 0.661

Gnomad AMR AF: 0.686

Gnomad ASJ AF: 0.514

Gnomad EAS AF: 0.653

Gnomad SAS AF: 0.684

Gnomad FIN AF: 0.682

Gnomad MID AF: 0.503

Gnomad NFE AF: 0.685

Gnomad OTH AF: 0.658

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.688 AC: 104499 AN: 151844 Hom.: 36250 Cov.: 30 AF XY: 0.688 AC XY: 51002 AN XY: 74180

African (AFR) AF: 0.718 AC: 29780 AN: 41448

American (AMR) AF: 0.686 AC: 10447 AN: 15218

Ashkenazi Jewish (ASJ) AF: 0.514 AC: 1782 AN: 3468

East Asian (EAS) AF: 0.653 AC: 3362 AN: 5150

South Asian (SAS) AF: 0.683 AC: 3293 AN: 4820

European-Finnish (FIN) AF: 0.682 AC: 7179 AN: 10528

Middle Eastern (MID) AF: 0.497 AC: 144 AN: 290

European-Non Finnish (NFE) AF: 0.685 AC: 46523 AN: 67904

Other (OTH) AF: 0.658 AC: 1386 AN: 2106

Alfa AF: 0.688 Hom.: 4278

Bravo AF: 0.688

Asia WGS AF: 0.650 AC: 2262 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.86
CADD	Benign	1.3
DANN	Benign	0.62
PhyloP100		-0.11
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs13131206; hg19: chr4-114043737;